Calamos Advisors’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-250,000
| Closed | -$2.47M | – | 1457 |
|
|
2022
Q2 | $2.47M | Hold |
250,000
| – | – | 0.01% | 844 |
|
|
2022
Q1 | $2.47M | Hold |
250,000
| – | – | 0.01% | 866 |
|
|
2021
Q4 | $2.51M | Hold |
250,000
| – | – | 0.01% | 826 |
|
|
2021
Q3 | $2.5M | Hold |
250,000
| – | – | 0.01% | 709 |
|
|
2021
Q2 | $2.51M | Hold |
250,000
| – | – | 0.01% | 655 |
|
|
2021
Q1 | $2.47M | Buy |
+250,000
| New | +$2.47M | 0.01% | 643 |
|